Terms: = Endocrine gland cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
140 results:
1. A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer.
Zhu SL; Qi M; Chen MT; Lin JP; Huang HF; Deng LJ; Zhou XW
Phytomedicine; 2024 Jun; 128():155377. PubMed ID: 38503154
[TBL] [Abstract] [Full Text] [Related]
2. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells.
Ravindran F; Mhatre A; Koroth J; Narayan S; Choudhary B
Life Sci; 2023 Dec; 334():122224. PubMed ID: 38084671
[TBL] [Abstract] [Full Text] [Related]
3. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis.
Wang F; Zhang Y; Pang R; Shi S; Wang R
Acta Pharm; 2023 Sep; 73(3):475-488. PubMed ID: 37708956
[TBL] [Abstract] [Full Text] [Related]
4. cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian cancer (HGSOC) Based on The cancer Genome Atlas Analysis.
Iżycka N; Zaborowski MP; Ciecierski Ł; Jaz K; Szubert S; Miedziarek C; Rezler M; Piątek-Bajan K; Synakiewicz A; Jankowska A; Figlerowicz M; Sterzyńska K; Nowak-Markwitz E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628927
[TBL] [Abstract] [Full Text] [Related]
5. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
6. Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells.
Wang H; Liu Y; Wang Y; Xu T; Xia G; Huang X
Cancer Med; 2023 Jul; 12(14):15277-15288. PubMed ID: 37409635
[TBL] [Abstract] [Full Text] [Related]
7. Evaluating the biological effectiveness of boron neutron capture therapy by using microfluidics-based pancreatic tumor spheroids.
Yu LY; Hsu CH; Li CY; Hong SY; Chen CR; Chen CS
Analyst; 2023 Jun; 148(13):3045-3056. PubMed ID: 37272284
[No Abstract] [Full Text] [Related]
8. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
9. Regulation of self-renewal in ovarian cancer stem cells by fructose via chaperone-mediated autophagy.
Sohn EJ; Kim JH; Oh SO; Kim JY
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166723. PubMed ID: 37087023
[TBL] [Abstract] [Full Text] [Related]
10. Low-dose BPA and its substitute BPS promote ovarian cancer cell stemness via a non-canonical PINK1/p53 mitophagic signaling.
Yuan X; Chen K; Zheng F; Xu S; Li Y; Wang Y; Ni H; Wang F; Cui Z; Qin Y; Xia D; Wu Y
J Hazard Mater; 2023 Jun; 452():131288. PubMed ID: 36989771
[TBL] [Abstract] [Full Text] [Related]
11. Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells.
Yuan L; Li P; Li J; Peng J; Zhouwen J; Ma S; Jia G; Jia W; Kang P
Acta Neuropathol Commun; 2023 Feb; 11(1):24. PubMed ID: 36750863
[TBL] [Abstract] [Full Text] [Related]
12. Anti-ovarian cancer actions and pharmacological targets of plumbagin.
Liang K; Pan X; Chen Y; Huang S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1205-1210. PubMed ID: 36692828
[TBL] [Abstract] [Full Text] [Related]
13. NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells.
Yun H; Han GH; Kim J; Chung JY; Kim JH; Cho H
J Cell Mol Med; 2022 Oct; 26(20):5277-5291. PubMed ID: 36114703
[TBL] [Abstract] [Full Text] [Related]
14. Prolyl 4-hydroxylase P4HA1 Mediates the Interplay Between Glucose Metabolism and Stemness in Pancreatic cancer Cells.
Cao X; Cao Y; Zhao H; Wang P; Zhu Z
Curr Stem Cell Res Ther; 2023; 18(5):712-719. PubMed ID: 36043766
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutic Targeting of Ovarian cancer Stem Cells Using Estrogen Receptor Beta Agonist.
He Y; Alejo S; Venkata PP; Johnson JD; Loeffel I; Pratap UP; Zou Y; Lai Z; Tekmal RR; Kost ER; Sareddy GR
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806169
[TBL] [Abstract] [Full Text] [Related]
16. Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[
Ohshima Y; Sasaki I; Watanabe S; Sakashita T; Higashi T; Ishioka NS
Nucl Med Biol; 2022; 112-113():44-51. PubMed ID: 35802985
[TBL] [Abstract] [Full Text] [Related]
17. PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis.
Sohn EJ
BMC Cancer; 2022 Jun; 22(1):708. PubMed ID: 35761259
[TBL] [Abstract] [Full Text] [Related]
18. 5-fluorouracil suppresses stem cell-like properties by inhibiting p38 in pancreatic cancer cell line PANC-1.
Zhao J; Shi X; Dong C; Liu R; Su L; Cao C
Folia Histochem Cytobiol; 2022; 60(1):55-65. PubMed ID: 35103981
[TBL] [Abstract] [Full Text] [Related]
19. Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-Kras
Yu W; Ma Y; Roy SK; Srivastava R; Shankar S; Srivastava RK
J Cell Mol Med; 2022 Jan; 26(2):399-409. PubMed ID: 34859959
[TBL] [Abstract] [Full Text] [Related]
20. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas.
Luan Z; Morimoto Y; Fushimi A; Yamashita N; Suo W; Bhattacharya A; Hagiwara M; Jin C; Kufe D
Carcinogenesis; 2022 Feb; 43(1):67-76. PubMed ID: 34657147
[TBL] [Abstract] [Full Text] [Related]
[Next]
